Some migrant groups in the European Union (EU), European Economic Area (EEA) and the United Kingdom (UK) have been disproportionately impacted by the coronavirus disease (COVID-19) pandemic, experiencing a range of health and social impacts. In addition, certain migrant groups have a known range of risk factors for low vaccine uptake and may face barriers to accessing health and vaccination systems. This report presents: 1) evidence around the clinical, health, and social impact that COVID-19 has had on migrant populations in EU/EEA countries and the UK; 2) risk factors and vulnerabilities in migrant populations to
COVID-19; and 3) considerations for ensuring equitable access to the COVID-19 vaccine rollout through identifying successes, lessons learned, and good practices to date.
Back to Database